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Lack of hypoxia-inducible factor-1 alpha impairs midbrain
neural precursor cells involving vascular endothelial growth
factor signaling
Abstract
Oxygen tension is critical for proliferation of human and murine midbrain-derived neural precursor cells
(mNPCs). Here, we conditionally inactivated the hypoxia-responsive transcription factor
hypoxia-inducible factor-1alpha (HIF-1alpha) in murine NPCs to determine its role in proliferation,
survival, and dopaminergic differentiation in vitro as well as survival of murine dopaminergic neurons
in vivo. HIF-1alpha conditional knock-out (HIF-1alpha CKO) mNPCs showed midbrain-specific
impairment of survival and proliferation. Dopaminergic differentiation of HIF-1alpha CKO mNPCs in
vitro was markedly reduced. Expression of vascular endothelial growth factor (VEGF) mRNA was
reduced in HIF-1alpha CKO mNPCs, whereas erythropoietin signaling was not affected. Treatment of
HIF-1alpha CKO mNPCs with 50 ng/ml VEGF partially recovered proliferation and dopaminergic
differentiation in vitro. In substantia nigra (SN) of adult HIF-1alpha CKO mice, protein levels of
dopaminergic marker molecules such as tyrosine hydroxylase (TH) and aldehyde dehydrogenase were
reduced by 41 and 61%, respectively. The cell survival marker Bcl-2 was reduced by 58% while
caspase-3 was activated. Nonbiased stereological cell counts of TH-positive neurons in SN of young
adult HIF-1alpha CKO mice revealed a reduction of 31% compared with cre/wt mice (in which the
wild-type Hif1a allele is expressed in parallel with the Cre recombinase allele). However, we found no
impairment of striatal dopamine concentrations or locomotor behavior. In conclusion, HIF-1alpha seems
to be a transcription factor relevant to the development and survival of substantia nigra dopaminergic
neurons involving VEGF signaling.
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Oxygen tension is critical for proliferation of human andmurinemidbrain-derived neural precursor cells (mNPCs). Here, we condition-
ally inactivated the hypoxia-responsive transcription factor hypoxia-inducible factor-1 (HIF-1) inmurine NPCs to determine its role
in proliferation, survival, and dopaminergic differentiation in vitro as well as survival of murine dopaminergic neurons in vivo. HIF-1
conditional knock-out (HIF-1 CKO)mNPCs showedmidbrain-specific impairment of survival and proliferation. Dopaminergic differ-
entiation of HIF-1 CKO mNPCs in vitro was markedly reduced. Expression of vascular endothelial growth factor (VEGF) mRNA was
reduced in HIF-1 CKO mNPCs, whereas erythropoietin signaling was not affected. Treatment of HIF-1 CKO mNPCs with 50 ng/ml
VEGF partially recovered proliferation and dopaminergic differentiation in vitro. In substantia nigra (SN) of adult HIF-1 CKO mice,
protein levels of dopaminergicmarkermolecules suchas tyrosinehydroxylase (TH) andaldehydedehydrogenasewere reducedby41 and
61%, respectively. The cell survival marker Bcl-2 was reduced by 58%while caspase-3 was activated. Nonbiased stereological cell counts
of TH-positive neurons in SNof young adultHIF-1CKOmice revealed a reductionof 31%comparedwith cre/wtmice (inwhich thewild-
type Hif1a allele is expressed in parallel with the Cre recombinase allele). However, we found no impairment of striatal dopamine
concentrations or locomotor behavior. In conclusion,HIF-1 seems to be a transcription factor relevant to the development and survival
of substantia nigra dopaminergic neurons involving VEGF signaling.
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Introduction
Neural precursor cells (NPCs) offer a great promise for develop-
ing new medical treatments for disorders such as Parkinson’s
disease (PD) (Gage, 2003; Alvarez-Buylla and Lim, 2004). It is
necessary to understand the mechanisms governing cell prolifer-
ation, dopaminergic differentiation, and senescence of NPCs to
facilitate clinical therapies (Sharpless and DePinho, 2004). Re-
duced oxygen tension is now recognized as a common require-
ment for successful expansion and dopaminergic differentiation
of NPCs (Ivanovic et al., 2000;Morrison et al., 2000; Studer et al.,
2000; Storch et al., 2001; Milosevic et al., 2005). Low, physiologic
oxygen conditions help maintain the undifferentiated state in
mouse NPCs, but the molecular mechanisms underlying oxygen
effects on NPCs are essentially unknown (Milosevic et al., 2005).
Many O2-responsive genes are regulated via hypoxia-
inducible factor-1 (HIF-1), a heterodimer consisting of HIF-1
andHIF-1 (also called aryl hydrocarbon receptor nuclear trans-
locatorm, or ARNT) (Semenza, 1999; Wenger, 2002). HIF-1
abundance is regulated by proteasomal degradation, and its ac-
tivity is regulated by diverse posttranslational modifications.
HIF-1 target genes include vascular endothelial growth factor
(VEGF), a potent inducer of angiogenesis, and erythropoietin
(EPO). Both have pleiotropic effects in the brain, including neu-
rogenesis and neuroprotection (Sakanaka et al., 1998; Junk et al.,
2002; Ferriero, 2005;Greenberg and Jin, 2005), aswell as substan-
tial regenerative effects on dopaminergic neurons (Studer et al.,
2000; Yasuhara et al., 2005).
HIF-1 is essential for the early development of many mam-
malian organs including brain (Ryan et al., 1998; Tomita et al.,
2003). Mice lacking HIF-1 show severe cardiac and vascular
malformations, leading to embryonic lethality at approximately
embryonic day 10.5 (E10.5) (Iyer et al., 1998). To study the im-
pact of HIF-1 on NPCs and, in particular, dopaminergic differ-
entiation of midbrain-specific NPCs (mNPCs), we conditionally
knocked out HIF-1 exon 2 in NPCs using Nestin promoter-
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driven expression ofCre recombinase (Betz et al., 1996; Rajewsky
et al., 1996). Exon 2 encodes themotif necessary for dimerization
of HIF-1 and HIF-1, binding of the HIF-1 dimer to DNA, and
its function as a transcription factor (Jiang et al., 1996). Our
findings indicate that HIF-1 promotes stem cell survival,
growth, and dopaminergic differentiation, as well as survival of
adult dopaminergic neurons.
Materials andMethods
Conditional inactivation of HIF-1 in NPCs. A Cre/loxP system was used
to generate HIF-1-deficient NPCs (Le and Sauer, 2000; Nagy, 2000).
Mice containing loxP-flanked Hif1a exon 2 (Hif1aloxP/loxP designated as
Hif1a-floxed mice) were kindly provided by R. S. Johnson (San Diego,
CA). The strategy used to obtain loxP-flanked Hif1a locus instead of the
endogenousHif1a locuswas described previously (Ryan et al., 2000) (Fig.
1A). Hif1a-floxed targeted mice were crossed with mice expressing Cre
recombinase under the control of theNestinpromoter,Nestin–Cre trans-
genic mice (JAXMICE; The Jackson Laboratory, Bar Harbor, ME). Nes-
tin–Cre strain of mice was maintained in a C57BL/6  SJL and Hif1a-
floxed in a C57BL/6 background. Animals heterozygous for bothHif1a-
floxed and Nestin–Cre alleles were mated to Hif1a-floxed homozygous
animals to generate Nestin–Cre, Hif1aloxP/loxP (HIF-1) mice. To dis-
tinguish HIF-1 conditional knock-out (CKO) embryos/mice, a
genomic PCR-based genotyping was applied using the following prim-
ers: floxed or wild-type (wt) HIF-1 allele, 5-GCAGTTAAGAGCACT
AGT TG-3 and 5-GGA GCT ATC TCT CTA
GAC C-3, 250 bp product (floxed) or 200 bp
product (wild type); Cre recombinase primers,
5-CCTGGAAAATGCTTCTGTCCG-3 and
5-CAG GGT GTT ATA AGC AAT CCC-3,
400 bp product (Fig. 1C). NPCs were dissected
from frontal (fNPCs) or mesencephalic brain
regions of HIF-1 null embryos carrying the
HIF-1 conditional mutation (HIF-1 CKO
fNPCs and HIF-1 CKOmNPCs, respectively)
as described below. Removal of HIF-1 exon 2
by Cre-induced recombination in NPCs was
confirmedusing the following primers: 5-GCA
GTT AAG AGC ACT AGT TG-3 and 5-TGT
TAA ATA AAA GCT TGG AC-3, amplifying a
650 bp fragment (Fig. 1D).
To exclude possible toxic effects of the Cre
recombinase that could influence proliferation
of NPCs, in all of our in vitro experiments, we
compared HIF-1 CKO NPCs with the cells
containing the wtHif1a allele expressed in par-
allel with the Cre allele, referred to as cre/wt
NPCs (Pfeifer et al., 2001).
Isolation, propagation, and differentiation of
NPCs. Mesencephalic and frontal (cortical)
NPCs were dissected from mice at E14. Preg-
nant females were killed according to National
Institutes of Health guidelines and the approval
of the local animal care committee. Tissue sam-
ples were incubated in 0.1 mg/ml papain
(Roche,Mannheim,Germany)/DNase solution
(100 g/ml; Roche) for 30 min at 37°C, rinsed
in PBS, incubated in antipain (50 g/ml;
Roche) for 30 min at 37°C, and finally homog-
enized by gentle triturating using a fire-
polished Pasteur pipette. The cells were ex-
panded as a monolayer culture by plating onto
polyornithine–fibronectin precoated dishes in
a density of 20,000 cells/cm2 (Milosevic et al.,
2005). The cells were maintained in serum-free
DMEM (high glucose)/F-12 mixture (1:1) me-
dium and supplemented with 20 ng/ml human
recombinant epidermal growth factor and 20
ng/ml basic fibroblast growth factor (both from
PromoCell, Heidelberg, Germany). NPCs were expanded in 3% oxygen
(Storch et al., 2001; Milosevic et al., 2005).
Differentiation of NPCs was induced using defined media without
mitogens but with 1% FCS and 5 M forskolin (Sigma-Aldrich, Munich,
Germany). Before electrophysiology, immunocytochemistry, or protein
extraction,mNPCswere allowed to differentiate for 1 week. Electrophys-
iological analysis of mNPCs was also performed after a 20 d differentia-
tion period.
In vitro VEGF administration. HIF-1 CKO and cre/wt mNPCs were
treated in vitrowith 50 ng/ml recombinant human VEGF (PAN Biotech,
Aidenbach, Germany), applied once for 7 d of proliferation and once
during consecutive 7 d differentiation period. Values obtained for treated
cultures were normalized to untreated ones.
Clonogenic survival assay. Midbrain-derived or frontal NPCs were
seeded in triplicate onto polyornithine–fibronectin precoated six-well
plates (1 103 cells per well in 3ml of culturemedium). Twoweeks after
incubation at 37°C in a reduced oxygen (3%) atmosphere, the colonies
were fixed in 70% ethanol and stained with 0.5% toluidine blue solution.
The number of colonies obtained for cre/wt control NPCs was consid-
ered as 100%, and colonies generated by HIF-1 CKO NPCs were nor-
malized to the control cells.
Immunoblotting. Mouse substantia nigra (SN) extracts or NPCs ex-
tracts were prepared as described previously (Milosevic et al., 2005).
Proteins (50–100g) were separated by 12%SDS-PAGE and transferred
to nitrocellulose membranes. Antibodies used to probe blots were as
Figure 1. Generation and characterization of neural precursor cells deficient for HIF-1. A, Exon 2 of the Hif1a allele was
flanked with loxP sites in two steps, resulting in generation of Hif1a-floxed mice. Hatched quadrangles represent loxP sites. B,
Hif1a-floxed mice were crossed with Nestin–Cre mice to generate HIF-1mutant mice (Nestin–Cre; Hif1aloxP/loxP or HIF-1 CKO
mice). C, PCR-based genotyping revealed embryos expressing both floxedHif1a allele (250 bp) and the Cre recombinase (400 bp),
identifying double transgenic or HIF-1 conditional mutants (HIF-1 CKO), whereas wild-type Hif1a allele (200 bp) and Cre
expression identified control (cre/wt) embryos. NPCs dissected from brains of both types of embryos were kept in culture and
subjected to additional analysis. NPCs from heterozygous embryos were discarded. D, PCR-based confirmation of Cre-mediated
recombination inNPCs. Exon2ofHif1awasexcisedbyCre-induced recombination inNPCs, resulting inappearanceof a shorter 650
bp band. DNA derived fromwt and HIF-1 KOMEFs was used as a positive and a negative control. E, Cre recombinase expression
was restricted to NPCs in vitro (Nestin-positive), as revealed by double immunofluorescence for Cre and Nestin (yellow color
indicates colocalization).
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follows: mouse monoclonal anti-proliferating
cell nuclear antigen (PCNA) (Santa Cruz Bio-
technology, Santa Cruz, CA); mouse monoclo-
nal anti-Bcl-2 (Santa Cruz Biotechnology),
mouse monoclonal anti-pro-caspase-3 (BD
Transduction Laboratories, San Jose, CA); rab-
bit polyclonal anti-activated caspase-3 (CM1;
BD PharMingen, San Diego, CA); mouse
monoclonal anti-VEGF (Abcam, Cambridge,
UK); chicken polyclonal anti-aldehyde dehy-
drogenase (ALDH1A1) (kindly provided by
N. E. Sladek,Minneapolis,MN);mousemono-
clonal anti-actin (MP Biomedicals, Eschwege,
Germany); mouse monoclonal anti-glial fibril-
lary acidic protein (GFAP) (Chemicon, Hamp-
shire, UK); rabbit polyclonal anti-HIF-1
(Cayman Chemical, Ann Arbor, MI); rabbit
polyclonal anti--tubulin III (anti-TUJ1; Co-
vance, Richmond, CA); and horseradish
peroxidase-conjugated secondary antibodies
(Pierce, Rockford, IL).
Immunocytochemistry.NPCs were fixed with
4% paraformaldehyde in PBS for 10 min at
room temperature, washed with PBS, and
counterstained with the DNA-binding dye 4-
6-diamidino-2-phenylindole (2 g/ml in PBS)
for 15 min at room temperature, twice washed
in PBS followed by incubation in blocking
buffer (10% FCS and 0.2% Triton X-100 in
PBS, pH 7.2) for 30 min at room temperature.
After incubation with the primary antibody (1
h at room temperature in blocking buffer), the
cells were incubatedwith fluorescent secondary
antibodies, Alexa Fluor 488 conjugate or Alexa Fluor 594 conjugate (In-
vitrogen, Carlsbad, CA). Coverslips were mounted onto glass slides and
examined under a fluorescence microscope (Axiovert 200; Zeiss, Jena,
Germany). Acquisition of the cells was performed using the image-
analysis software AxioVision 4 (Zeiss, Jena, Germany). The following
primary antibodies were used for immunofluorescence: mouse mono-
clonal anti-nestin (BD Biosciences, San Jose, CA), mouse monoclonal
anti-Cre recombinase (Chemicon), and rabbit polyclonal anti--tubulin
III (anti-TUJ1; Covance).
Confocal microscopy. Activated caspase-3 localization in the SN was
investigated by confocal laser scanning microscopy (LSM 510; Zeiss,
Oberkochen, Germany) at an excitation wavelength of 594 nm (helium/
neon, red Alexa 594 immunofluorescence) and 488 nm (argon, yellow–
green Alexa 488 immunofluorescence).
Immunohistochemistry and stereological cell counts.After being fixed by
cardiac perfusion (4% paraformaldehyde in phosphate buffer) both
HIF-1KOand cre/wtmice brainswere postfixed for 2 h and dehydrated
in 15% sucrose and 30% sucrose. Frozen brain samples were cut (40m)
in a cryostat; 10–20 serial sections from SN levels were collected free
floating in ice-cold PBS. Double immunostaining was performed with
antisera for tyrosine hydroxylase (TH) (goat polyclonal anti-TH anti-
body, 1:100; Santa Cruz Biotechnology) and anti-activated caspase-3
(CM1, 1:2000; BD PharMingen), followed by incubation with fluores-
cent secondary antibodies (1:500, Alexa 488 or Alexa 594; Invitrogen).
For stereology, groups of three to four transgenic mice of the same age (4
weeks old) were perfused as described above. TH-positive cells in the SN
from HIF-1 CKO and cre/wt mice were selected for nonbiased quanti-
tative stereology. Tissue sections, 40m thick (8–12 slices), were chosen
for analysis using systematic random sampling. The SN sections were
immunostained with a rabbit antibody to TH (rabbit polyclonal; Santa
Cruz Biotechnology) at a 1:500 dilution, biotinylated goat anti-rabbit
secondary antibody, streptavidin–HRP (Vector Laboratories, Burlin-
game, CA), and DAB (Sigma-Aldrich). Before dehydration of floating
slices, they were processed for Nissl (30 s in 0.5% toluidine blue in PBS)
to facilitate counting. The intersection interval, counting frame size, and
distance between counting frames were adjusted so that, whenever pos-
sible, a reasonable number of TH-stained cells were sampled. The optical
fractionator method was used to provide an unbiased estimation of the
total number of dopaminergic neurons in the region of interest. Stereo-
logic counting and estimates were donewith the aid of Stereoinvestigator
version 5.05.1 (MicroBrightField, Magdeburg, Germany) (Orb et al.,
2004).
Electrophysiology. Patch-clamp analysis of mNPCs differentiated in
vitro for 7 or 20 d was performed at room temperature using an inverted
microscope DMIL (Leica, Bensheim, Germany) and an EPC-9 amplifier
(HEKA Elektronik, Lambrecht, Germany). Recordings of voltage-gated
ion channels were obtained in the whole-cell voltage-clamp mode by
stepwise depolarizations with increasing amplitudes from the holding
potential of70 to 50mV in steps of 10mV. Series resistance values were
continuouslymeasured during all recordings. The external bath solution
contained the following (in mM): 142 NaCl, 1 CaCl2, 8 KCl, 6 MgCl2, 10
glucose, and 10HEPES, pH 7.4 (320mOsm).Micropipettes were formed
from thin-walled borosilicate glass (Science Products, Hofheim, Ger-
many) with a Flaming Brown electrode puller P-97 (Sutter Instruments,
Novato, USA) and a Micro Forge (Narishige, Tokyo, Japan). Electrodes
had resistances of 2–4 M when filled with the internal solution con-
taining the following (inmM): 153KCl, 1MgCl2, 10HEPES, 5 EGTA, and
2 MgATP, pH 7.3 (305 mOsm). Whole-cell currents were low-pass fil-
tered at 2–5 kHz, digitized at 10 kHz, and analyzed using PulseFit soft-
ware (HEKA Elektronik) and Prism 4 (GraphPad Software, San Diego,
CA). Data were expressed as mean  SEM. Statistical significance was
considered at p 0.05 (Student’s t test, two-tailed, unpaired).
Determination of dopamine and metabolites. For determination of do-
pamine, norepinephrine, and their metabolites, striatal tissue was dis-
sected and immediately frozen in liquid nitrogen. Five striata of each
genotype were processed. Dopamine, norepinephrine, 3,4-
dihydroxyphenylacetic acid (DOPAC), and homovanillic acid were ana-
lyzed using standardHPLC techniques essentially as described previously
(Gerlach et al., 1996).
Behavioral studies. Sensorimotor performance of HIF-1 CKO com-
pared with cre/wt mice was evaluated using the beam-walk paradigm.
Mice were trained to pass a beam for 4 consecutive days. We used a
Table 1. Primers for quantitative real-time RT-PCR
Gene (protein) Primer sequence: forward: reverse GenBank accession #
Aldoa (aldolase A) 5-CAA CGG TCA CAG CAC TTC G-3 NM_007438
5-GGC TCG ACC ATA GGA GAA AG-3
Car9 (carboanhydrase 9) 5-CGA TTG AGG CTT CCT TCC C-3 NM_139305
5-CTA ACT CTA TCT TTG GTC CCA CTT C-3
Epo (erythropoietin) 5-GAA AAT GTC ACG ATG GGT TGT-3 NM_007942
5-TGT TCT TCC ACC TCC ATT CTT T-3
EpoR (erythropoietin receptor) 5-CTC ATT CTG GTC CTC ATC TCG-3 NM_010149
5-CAC CAC AGA CAA CCA TCA CG-3
Gapdh (glycerin-aldehyde-3-phosphatase) 5-AGG TTG TCT CCT GCG ACT TCA-3 NM_001001303
5-GGT GGT CCA GGG TTT CTT ACT C-3
Hk1 (hexokinase 1) 5-GCC ATT GAA ACG GAT AAG GAA-3 NM_010438
5-GGC TGA TCG GAA GGA GAC G-3
Hmbs (hydroxymethylbilane synthase) 5-TCG GGG AAA CCT CAA CAC C-3 NM_013551
5-CCT GGC CCA CAG CAT ACA T-3
Ldha (lactate dehydrogenase A) 5-GCG GTT CCG TTA CCT GAT G-3 NM_010699
5-GAA CCT CCT TCC ACT GCT CC-3
Slc2a1 (glucose transporter 1) 5-GCT TCC TGC TCA TCA ATC GTA A-3 NM_011400
5-CGA CCC TCT TCT TTC ATC TCC T-3
Slc2a3 (glucose transporter 3) 5-TCA ACC GCT TTG GCA GAC-3 NM_011401
5-CGA AGG GCA GTG GGA GAC-3
Vegf (vascular endothelial growth factor) 5-GCT ACT GCC GTC CGA TTG-3 NM_001025257
5-CTG CAG GGC TTC ATC GTT AC-3
VEGFR1 Flk1 (FMS-like tyrosine kinase 1) 5-GAC ATT ACC TGG ATT CTG CTA CG-3 NM_010228
5-AAG GAT GTC TTC CCC TGT GTA 5-3
VEGFR2 Flk1 (fetal liver kinase 1) 5-GGA CCT GGC AGC ACG AA-3 NM_010612
5-CAC TTC AAA GGG AGT CGG G-3
VEGFR3 Flt4 (FMS-like tyrosine kinase 4) 5-ACG CTG ATG ATA GTC CAC CC-3 NM_008029
5-CGC TGT CTG TCT GGT TAT CC-3
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wooden beam with a length of 1 m, a diameter of 4 mm, and a rough
surface to prevent slipping.Mice weremotivated via the smell of the food
within the target cage.On the fifth day, 10 trials permousewere analyzed.
Spontaneous locomotion was measured for 30 min using an open-
field setup. Transitions from one quadrant to another were scored. All
open-field experiments were videotaped and analyzed subsequently by a
blinded rater (J.L.).
RNA extraction and quantitative real-time reverse transcription-PCR
analysis. Total cellular RNA was extracted from NPCs using RNAeasy
total RNA purification kit followed by treatment with RNase-free DNase
(Qiagen, Hilden, Germany). Semiquantitative real-time one-step reverse
transcription (RT)-PCR was performed using the Stratagene system
(MX3000P; Stratagene, Heidelberg, Germany), and amplification was
monitored and analyzed by measuring the binding of fluorescent SYBR
Green I to double-stranded DNA. One microliter (50 ng) of total RNA
was reverse transcribed and subsequently amplified using QuantiTect
SYBR Green RT-PCR Master mix (Qiagen) and 0.5 mol/L of both sense
and antisense primers. The sequences for forward and reverse primers used
for the target gene (TG) and the reference gene (RG) hydroxymethylbilane
synthase are summarized in Table 1. The relative RNA content was deter-
mined using the formula of the comparative cycle threshold (Ct): TG/RG
2Ct(RG)  Ct(TG) (Livak and Schmittgen, 2001). The efficiency of product
formation by PCR was estimated from plots of Ct values versus serial
dilutions, measured three times with different RNA samples.
Statistical analysis.Normally distributed data were subjected to statis-
tical analyses as indicated (one- or two-way ANOVA) using the SigmaS-
tat software package (Jandel, San Rafael, CA) and Prism 4. Results are
expressed as the mean SEM. Statistical significance was considered at
p 0.05.
Results
Generation and characterization of HIF-1 CKO mNPCs
Hif1a-floxed targeted mice were crossed with mice expressing
Cre recombinase under the control of theNestin promoter (Nes-
tin–Cre mice) to obtain Nestin-Cre; HIF-1loxP/loxP (HIF-1)
mice referred to HIF-1 CKOmice (Fig. 1A,B). NPCs were dis-
sected from both midbrain and frontal
part of each embryonic brain and ex-
panded in vitro. After genotyping, only
NPCs containing the wt Hif1a allele that
were cre-positive (cre/wt), as well as NPCs
containing the Hif1-floxed allele that
were cre-positive (HIF-1 CKO) were
kept in culture for additional analysis (Fig.
1C,D). HIF-1/ homozygous mutant
myocyte enhancer factors (MEFs) and wt
MEFs were used as a negative and positive
control for the genotyping (Fig. 1D). Im-
munocytochemical staining confirmed
expression of Cre recombinase in Nestin-
positive NPCs (Fig. 1E).
Wild-type murine NPCs (cre/wt) and
NPCs lacking exon 2 of the Hif1a gene,
designated as HIF-1CKO dissected from
at least four different embryos were ex-
panded in 3% oxygen and checked for ex-
pression of HIF-1 protein. In cre/wt
NPCs, HIF-1 protein was stabilized in
3% oxygen revealing a 120 kDa band as
seen by immunoblotting. This band was
not present inHIF-1CKOcells (Fig. 2A).
As soon as successful Cre-mediated exci-
sion was confirmed in NPCs, these cells
were considered as HIF-1 knock-outs.
HIF-1 is important for survival and
proliferation of midbrain-derived NPCs
mNPCs generated from at least four different embryos were first
expanded for 2 weeks in 3% oxygen and then split for additional
expansion for 2weeks, in either 20 or 3%oxygen. Protein extracts
were probed with the proliferation marker PCNA and prosur-
vival marker Bcl-2. Compared with cre/wt cells, expression of
both proteins was significantly reduced in HIF-1 inactive NPCs
when they were expanded in 3% oxygen. As shown in Figure 2A,
PCNA expression was reduced to 61  13% (n  4; p  0.035,
one-way ANOVA), whereas Bcl-2 levels were only 34  11% in
HIF-1 CKO mNPCs (n  4; p  0.015). When HIF-1 was
eliminated by 20% oxygen, PCNA and Bcl-2 expression did not
significantly differ in HIF-1 CKO mNPCs compared with
cre/wt mNPCs (Fig. 2B).
Clonal assays confirmed the necessity of HIF-1 for survival
and proliferation of mNPCs. Mesencephalic NPCs derived from
HIF-1CKO embryonic brains in 3%oxygen produced 20 4%
colonies normalized to 100% colonies formed by cre/wt NPCs
(Fig. 2C,D).
HIF-1 is not necessary for survival and proliferation of
frontal NPCs
To test region-specific effects of HIF-1 deletion in NPCs, we
performed the same experimental procedure on frontal NPCs.
Proliferation (PCNA protein expression) and survival (Bcl-2
protein expression) assessed by Western blotting did not reveal
any significant differences in HIF-1 null compared with cre/wt
NPCs in either 3 or 20% oxygen (Fig. 3A,B). Frontal NPCs de-
rived from HIF-1 CKO embryonic brains in 3% oxygen pro-
duced a similar number of colonies compared with cre/wt sam-
ples (98 3%) (Fig. 2D).
Figure 2. Survival and proliferation of HIF-1 CKO mNPCs are impaired. A, Western blot analysis of HIF-1 wild-type and
HIF-1 CKO mNPCs grown in either 3 or 20% oxygen revealed impaired proliferation (PCNA) and survival (Bcl-2) of HIF-1 CKO
mNPCs. B, Twenty percent of oxygen caused no changes in expression of PCNA and Bcl-2 in either cre/wt or HIF-1 CKOmNPCs.
C, Reduced number of clones formed by HIF-1 CKO versus cre/wt mNPCs in 3% oxygen is shown. D, Numbers of generated
colonies [colony-forming units (CFU)], either fNPCs or mNPCs, expressed as a percentage of the colonies formed by cre/wt NPCs.
*p 0.05 compared with cre/wt NPCs.
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HIF-1 is important for in vitro neuronal and dopaminergic
differentiation of midbrain-derived NPCs
Whole-cell extracts for Western blotting were acquired from
NPCs after 4 weeks of proliferation and after 1 week of differen-
tiation. Extracts were separated and probed with the neuronal
marker (TUJ1), the glial marker (GFAP), or TH, a marker for
dopaminergic neurons. As shown in Figure 4A, neuronal and
glial markers were not significantly changed in fNPCs, whereas
differentiated HIF-1 CKO mNPCs exhibited a significant re-
duction in TH expression, 35 4% of wt ( p 0.001). Neuronal
differentiation andmorphology of NPCs from frontal cortex was
not affected by HIF-1 deletion as confirmed by immunocyto-
chemical analysis of frontal NPCs (Fig. 4B). In both KO and
cre/wt differentiated fNPCs, extensive neuronal processes were
observed. Furthermore, protein expression of TUJ1 and GFAP
did not vary between two different cell types (Fig. 4C). However,
TUJ1 staining on cultured mNPCs 1 week after differentiation in
3% oxygen showed an altered morphology in HIF-1 CKO
mNPC compared with cre/wt NPCs. Cre/wt neurons were more
mature, exhibiting longer neurites (Fig. 4D).
Electrophysiological analyses of voltage-gated ion channels
showed significantly decreasedmaximal sodium inward currents
of HIF-1 CKO mNPCs (116.9  33.9 pA) 7 d after in vitro
differentiation compared with cre/wt NPCs (318.2  77.7 pA;
n  12 for each genotype; p  0.032, t test), whereas no signifi-
cant reduction was calculated for potassium outward rectifying
currents (Fig. 5). After 20 d of mNPC differentiation, values for
sodium and potassium currents were increased in both HIF-1
CKO and cre/wt cells without altering the difference between the
two genotypes (data not shown). In contrast, there was no signif-
icant difference inmaximal amplitudes of sodium and potassium
currents between HIF-1CKO and cre/wt frontal NPCs 7 d after
in vitro differentiation (data not shown).
HIF-1 supports the development and/or survival of
dopaminergic neurons
SN was dissected from 4-week-old HIF-1 CKO mice and their
cre/wt littermates. At the time of analysis, these animals were
macroscopically identical. Tissue extracts were analyzed via im-
munoblotting. Neuronal-tubulin III (TUJ1) expression did not
significantly differ between genotypes, whereas TH protein was
reduced to 59  5% in HIF-1 CKO mice (n  5; p  0.008, t
test). The expression of ALDH1A1, another early marker of SN
dopaminergic neurons, was reduced to 39  19% (n  5; p 
0.002). Prosurvival protein Bcl-2 was reduced to 43 12% (n
Figure 3. Survival and proliferation of HIF-1 CKO fNPCs. A,B, Western blot analysis of HIF-1
wild-type andHIF-1CKO fNPCsgrown in either 3 or 20%oxygen showedno changes in expression
of proliferationmarker PCNAand the prosurvivalmarker Bcl-2.
Figure 4. Differentiation potential of frontal (cortical) andmesencephalic NPCs. A–D, Fron-
tal (A, B) and mesencephalic (C, D) NPCs were first expanded in 3% oxygen for at least eight
passages and then were subjected to differentiation for 1 week, which was also in reduced
oxygen. Protein extracts were probedwith the early neuronal marker-tubulin III (TUJ1), glial
marker (GFAP),marker for dopaminergic neurons (TH), and loading control (-actin). Data inA
and C are mean SEM values from at least three independent experiments. *p 0.05 when
compared with cre/wt NPCs. Immunofluorescence TUJ1 staining of differentiated HIF-1 CKO
and cre/wt frontal (B) or mesencephalic (D) NPCs is shown. Immunostaining of midbrain-
derived NPCs has revealed diverse neuronal morphology characterized like reduced axonal
branching in CKO versus wt cells.
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5; p 0.03). Pro-caspase-3 was cleaved in HIF-1CKOmice SN
extracts, resulting in reduced levels of 20  15% (n  5; p 
0.008), but activated caspase-3 was increased because it was not
detectable in extracts from cre/wt mice. VEGF protein was re-
duced in SN taken fromHIF-1CKOcomparedwith cre/wtmice
(Fig. 6A). Double-immunofluorescence labeling of brain slices in
combination with confocal laser scanning microscopy indicated
that the activated, cleaved form of the caspase-3 was predomi-
nantly present in dopaminergic (TH-positive) cells in the SN of
HIF-1 CKOmice (Fig. 6B). In the SN of cre/wt mice, we could
not find any cells positive for both caspase-3 and TH.
Finally, stereological non-biased counts of TH-positive cells
in the SN of HIF-1 CKO mice (n  4)
showed a robust and significant reduction
comparedwith cre/wt SN (total number of
TH-positive neurons in the SN, 7489 
477 vs 10,817 903, respectively, or 69
6% of cre/wt) (Fig. 6C). However, the
number of TH-positive cells in another
brain region, ventral tegmental area
(VTA), remained unaffected (n 4) (Fig.
6C). Nissl staining of both cre/wt and
HIF-1 CKO brain slices revealed no dif-
ference in the SN (50,096  246 vs
48,913  2006, respectively; n  3), den-
tate gyrus (375,897 61,210 vs 364,628
30,580), and medial habenula (84,560 
6141 vs 79,318  5740). In addition, bio-
chemical measurements of dopamine,
norepinephrine, and their metabolites
(DOPAC andHVA) did not reveal any sig-
nificant differences between genotypes
(data not shown). These findings are well
in linewith othermousemodels of Parkin-
son’s disease, in which moderate losses of
dopaminergic neurons within SN are
readily compensated (Orb et al., 2004).
An evaluation of potential sensorimo-
tor deficits using analysis of beam walking
and spontaneous locomotion failed to
show any difference between genotypes
(data not shown). Open-field behavior of
HIF-1 CKO and cre/wt mice was quanti-
fied for 30 min. Statistical analysis by two-
tailed t test revealed no statistical differ-
ences between HIF-1 CKO and cre/wt
mice (n 7 of both genotypes).
Expression analysis of HIF-1-
regulated genes revealed VEGF and
VEGF receptors as major downstream
genes of HIF-1 in mNPCs
The expression of VEGF and VEGF recep-
tor (VEGFR) subtypes as HIF-1 regu-
lated genes was explored and quantified in
expandedmNPCs and fNPCs by real-time
RT-PCR. VEGF expression was reduced in
HIF-1CKOmNPCs comparedwith both
cre/wt mNPCs and fNPCs (n  7; p 
0.036) (Table 2, Fig. 7A) but showed no
change between both fNPC subtypes. Ex-
pression levels of VEGFR-1 (Flt-1) were
significantly higher in mNPCs compared
with fNPCs independent of HIF-1 expression (Table 2).
VEGFR-2 (Flk-1) expression was 2.7- to 3.8-fold increased in
HIF-1CKOcomparedwith cre/wtNPCs in bothmesencephalic
and frontal NPCs and 31- to 44-fold higher in mNPCs compared
with fNPCs independent ofHIF-1 expression (n 4; p 0.018)
(Table 2, Fig. 7A). VEGFR-3 (Flt-4) expression did not differ
between HIF-1 CKO and cre/wt mNPCs. We did not detect
differences in mRNA levels of the EPO receptor (EPOR) in
HIF-1 CKO and cre/wt mNPCs and fNPCs (data not shown).
Additionally, there were no detectable mRNA levels of EPO in all
four cell types. Significantly lower expression of neuronal glucose
transporter 3 (Slc2a3) in both fNPC subtypes and in HIF-1
Figure5. Voltage-gated ion channels ofmurinemesencephalicNPCsafter 7d in vitrodifferentiation.A,B, Recordingsof cre/wt
(A) and HIF-1 CKO (B) cells were obtained in whole-cell voltage-clamp mode by stepwise depolarizations with increasing
amplitudes from the holding potential of70 to 50mV in steps of 10mV. Note the inlays showing sodium inward currents that
were more pronounced in cre/wt (A) than in HIF-1 CKO (B) cells. C, D, Current–voltage plots of mNPCs show higher values for
mean amplitudes of sodium inward and potassium outward currents in cre/wt (C) than in HIF-1 CKO (D) cells. Maximal sodium
inward currents (E) of HIF-1 CKONPCswere significantly decreased comparedwith cre/wt cells ( p 0.032, t test), whereas no
significant reduction was calculated for potassium outward rectifying currents; all current values are shown as means SEM.
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CKO mNPCs compared with cre/wt mN-
PCs were seen (Table 2). In contrast, we
did not detect significant differences in
mRNA levels of various other non-
neuronal HIF-1-regulated genes with re-
spect to the four NPC subtypes (Table 2).
VEGF stimulates proliferation and
dopaminergic differentiation of HIF-1
CKOmNPCs in vitro
Because VEGF seemed to be reduced in
HIF-1 CKOmNPCs and potentially me-
diate the effects ofHIF-1 in these cells, we
tried to rescue HIF-1 CKO mNPCs by
supplementing culture media with VEGF.
Proliferation, analyzed by PCNA expres-
sion, was significantly increased inHIF-1
CKO mNPCs after application of VEGF
(50 ng/ml) (47 5% in untreated vs 75
4% in VEGF-treated cells; p  0.05, two-
way ANOVA). In addition, TH protein
was elevated from 26  5% of control in
untreated HIF-1 CKO mNPCs to 68 
6%afterVEGF treatment (n 4; p 0.05)
(Fig. 7B,C). Proliferation of cre/wt cells
did not significantly change after VEGF
treatment. The prosurvival protein Bcl-2
and the neuronal marker TUJ1 were not
altered by VEGF treatment in either cell
type (Fig. 7B,C). Thus, only partial recov-
ery of HIF-1CKOmNPCs proliferation and differentiation was
induced by VEGF in vitro administration.
Discussion
Here we demonstrate for the first time that HIF-1 is impor-
tant for proliferation, survival, and differentiation of murine
tissue-specific midbrain-derived NPCs. Thus, HIF-1may be
an essential mediator with respect to the beneficial effects of
lowered oxygen tension on NPCs (Studer et al., 2000; Storch et
al., 2001; Milosevic et al., 2005). Adult HIF-1-deficient mice
also showed deficits of SN dopaminergic neurons, indicating
that HIF-1 is not only important for proliferation and differ-
entiation of mNPCs in vitro butmay alsomediate regeneration
or survival in vivo.
Gas phase oxygen concentrations of 1–5% correspond to the
physiological environment in embryonic tissue and adult brain
(Silver and Erecinska, 1998). These “physiological” concentra-
tions seem to be required for stem cell maintenance (Gustafsson
et al., 2005; Covello et al., 2006). Recently, we demonstrated that
“room air” damagesmurinemidbrain-derivedNPCs, initiating a
variety of cellular events (Milosevic et al., 2005). However, it was
not clear whether 3% oxygen affects NPC proliferation and dif-
ferentiation via an HIF-1-dependent signaling pathway or via
another mechanism.
Table 2. Gene expression profile of HIF-1-regulated genes in NPCs grown under 3% oxygen conditiona
Genes (protein) HIF-1 CKO mNPCs cre/wt mNPCs HIF-1 CKO 1NPCs cre/wt fNPCs p valueb
Aldoa (aldolase A) 5.66 0.66 6.94 2.02 6.88 1.31 9.45 0.76 0.16
Car9 (carboanhydrase 9) 0.01 0.00 0.02 0.01 0.06 0.02 0.14 0.09 0.10
Epo (erythropoietin) n.d. n.d. n.d. n.d.
EpoR (erythropoietin receptor) 0.07 0.01 0.06 0.01 0.06 0.02 0.09 0.02 0.69
Gapdh (glycerin-aldehyde-3-phosphatase) 93.1 24.7 166.2 34.6 173.1 43.0 278.6 21.9 0.24
Hk1 (hexokinase 1) 2.71 0.23 1.96 0.35 1.71 0.24 2.56 0.20 0.23
Ldha (lactat deydrogenase A) 26.0 2.54 74.4 21.3 31.3 2.29 57.6 6.79 0.18
Slc2a1 (glucose transporter 1) 0.65 0.05 1.24 0.61 0.92 0.43 1.92 0.88 0.38
Slc2a3 (glucose transporter 3) 0.16 0.01* 0.38 0.06 0.07 0.02*		 0.17 0.04		 0.00015
Vegf (vascular endothelial growth factor) 8.85 2.42* 18.7 8.9 13.7 1.4	 18.4 6.1 0.036
VEGFR1/Flt1 (VEGF receptor 1/FMS-like tyrosine kinase 1) 0.21 0.11 0.19 0.07 0.04 0.03	 0.07 0.02	 0.028
VEGFR2/Flk1 (VEGF receptor 2/fetal liver kinase 1) 0.30 0.06* 0.11 0.06 0.0095 0.001**,		 0.0025 0.001		 0.0008
VEGFR3/Flt4 (VEGF receptor 3/FMD-like tyrosine kinase 4) 0.07 0.03 0.11 0.09 0.0029 0.001 0.0039 0.001 0.19
n.d., Not detectable.
a mRNA levels of the target gene relative to the housekeeping gene Hmbs (mean SEM) from three to seven experiments.
b p values from ANOVA tests for multiple group comparisons (n 3–7); post hoc t test revealed statistical significant differences with *p 0.05 and **p 0.01 when compared with control NPCs (cre/wt mNPCs or cre/wt fNPCs);	p
0.05 and		p 0.01 when compared with the respective mNPC subtype.
Figure 6. Degeneration of the SN of HIF-1 CKO mice. A, Immunoblots demonstrating TH and ALDH1A1 protein expression,
neuronal-tubulin III (TUJ1) expression, apoptotic effectors such as Bcl-2, pro-caspase-3, and activated caspase-3, and HIF-1
downstream target genes such as VEGF, all parallel assessed in the SN of HIF-1 CKO and cre/wt mice. B, SN of HIF-1 CKOmice
viewed by confocal microscopy showing colocalization of activated caspase-3 (CM1; red) in TH-immunoreactive cells (green). C,
Stereological investigation revealing the number of dopaminergic (TH-positive) neurons in the SN and the ventral tegmental area
of HIF-1 CKO in relation to cre/wt mice is presented. Scale bar, 40m. Data are expressed as mean SEM values from five
independent experiments. *p 0.05 when compared with cre/wt NPCs.
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In an attempt to elucidate the role of HIF-1 in 3% oxygen-
stimulated survival, proliferation, and differentiation in murine
NPCs, we conditionally targeted HIF-1 in NPCs using a Cre/
loxP-based system (Ryan et al., 2000). Tomita et al. (2003)
created mice with neural-cell-specific HIF-1 deficiency, ex-
hibiting hydrocephalus, neuronal loss, and impairment of
spatial memory. In the present paper, we focused on the mid-
brain dopaminergic system, investigating possible alterations
of dopaminergic markers (ALDH1A1, TH, dopamine, and
metabolites) and expression of major HIF-1 downstream
proteins, such as VEGF and EPO. Deletion of HIF-1 in mN-
PCs had an impact on neuronal morphology in vitro accom-
panied by a significant reduction of sodium inward currents
elicited by depolarizations, suggesting an altered morpholog-
ical and functional differentiation compared with cre/wt
mNPCs. In this regard, cortical NPCs remained unaffected.
Midbrain-derived NPCs also showed decreased levels of TH
after differentiation. In contrary to the major finding by To-
mita et al. (2003), which was apoptosis in the cortical plate
resulting in cortical atrophy in HIF-1 null mutant mice, we
did not observe any significant changes regarding prolifera-
tion, survival, and neuronal differentiation in frontal (corti-
cal) NPCs. In addition, we did not notice any alterations in
cortical brain regions in 4-week-old mice, which, according to
Tomita et al. (2003), at that age should have been visible. Our
HIF-1 CKO mice were macroscopically indistinguishable
from cre/wt mice but exhibited morphological alterations in
the SN. However, our mice did not show major locomotor
deficits or dopamine deficiency within striatal tissue, suggest-
ing that the moderate loss of dopaminergic neurons at that age
was well compensated. HIF-1 functional mutants developed
by Tomita et al. (2003) were created also using Cre/loxP tech-
nology but excising exons 13–15 of the HIF-1 gene while we
excised exon 2. HIF-1 mutant protein in the report by To-
mita et al. (2003) lacked the transactivation domain, whereas
our HIF-1mutant mice lack the DNA binding domain. Thus,
the HIF-1 mutant protein was either absent or functionally
inert (Jiang et al., 1996; Ema et al., 1999). At this point, it is not
clear whether the differences seen between two HIF-1 CKO
mice originate as a consequence of a different genetic manip-
ulation, differences in genetic background, or other reasons.
HIF-1might be protective in some neurological disorders
(Soucek et al., 2003). Neuroprotective effects of EPO on do-
paminergic neurons suggested a possible positive effect of
hypoxia via HIF-1 and subsequent EPOR expression (Dem-
ers et al., 2005). In line with recent studies suggesting a pivotal
role of HIF-2 in regulating EPO expression (Chavez et al.,
2006), we did not find relevant EPO expression in our cell
system and no differences of EPOR expression in HIF-1CKO
versus cre/wt mNPCs, suggesting that EPOR signaling is not
involved in HIF-1-dependent survival, proliferation, and
differentiation of mNPCs. Conversely, VEGF as another
downstream target gene of HIF-1 acts as a direct neurotro-
phic or even neuroprotective factor (Matsuzaki et al., 2001;
Sun et al., 2003). We detected a notable reduction in VEGF
mRNA expression in HIF-1 CKO compared with cre/wt
mNPCs and a most likely compensatory upregulation of
VEGFR-2. SN of HIF-1 CKO mice expressed less VEGF pro-
tein compared with cre/wt.We further demonstrated that pro-
liferation and dopaminergic differentiation of HIF-1 CKO
mNPCs were partially recovered after in vitro administration
of VEGF, indicating that other target genes besides VEGF are
involved. The lack of HIF-1 coincided with apoptotic cell
death in dopamine-producing, TH-positive cells in the SN of
adult mice. Procaspase-3 was cleaved in the SN of HIF-1
CKO mice confirmed by in situ caspase-3 activation. Expres-
sion of the anti-apoptotic protein Bcl-2 in SN of HIF-1 CKO
mice was decreased, likely as a consequence of an effector
caspase activation (Milosevic et al., 2003). However, HIF-1
CKO mice exhibited absence of gross locomotor and sensori-
motor behavioral deficits, which is in line with other mouse
models with moderate dopaminergic deficits (Masliah et al.,
2000; Orb et al., 2004).
HIF-1 activates the expression of hypoxia-inducible genes
that contain a hypoxia response element located in the pro-
moter or enhancer regions. Hypoxia induces TH mRNA ex-
pression in rat mesencephalic cultures (Leclere et al., 2004),
whereas HIF-1 contributes to induction of TH transcription
in PC12 cells (Schnell et al., 2003). Our findings indicate that
HIF-1 represents an important factor for in vitro neuronal
and dopaminergic differentiation, as well. Conditional knock-
Figure 7. VEGF partially restores proliferation and dopaminergic differentiation of HIF-1
CKO mesencephalic NPCs expanded in 3% oxygen. A, Compared with cre/wt, VEGF mRNA ex-
pression is reduced in HIF-1 CKOmNPCs, whereas VEGFR-2 expression is increased in the CKO
as observedby semiquantitative RT-PCRanalysis.B,C, Proliferation (B) (PCNAandBcl-2 protein
expression) and differentiation (C) (TH protein expression, TUJ1 expression) markers observed
in HIF-1 CKO mNPC untreated and treated with VEGF relative to cre/wt untreated values are
shown. VEGF (50 ng/ml) was applied for 7 d of proliferation followed by 7 d of differentiation.
Data are mean SEM values from at least four independent experiments. *p 0.05 when
compared with cre/wt mNPCs.
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out of HIF-1 affected SN neurons in young adult mice. In
addition to the decline of TH expression, we observed a
reduction in another neuronal marker enriched in SN,
ALDH1A1. ALDH1A1 is shown to be expressed in A9 dopa-
minergic neuronal group, the most vulnerable site in PD
(Chung et al., 2005). We showed a prominent reduction in the
number of dopaminergic (TH-positive) neurons in the SN of
HIF-1-deficient mice. Many animal models with degenera-
tion of dopaminergic neurons show specificity for dopaminer-
gic neurons in SN compared with VTA (Liss et al., 2005; Main-
gay et al., 2006). Accordingly, HIF-1-deficient mice have no
deficit in A10 dopaminergic neurons. Moreover, as revealed
by Nissl staining, other neuronal types (e.g., GABAergic neu-
rons in gyrus dentatus or SN, catecholaminergic neurons in
medial habenula) likely also remained unaffected in HIF-1
CKO, because examined brain regions did not exhibit differ-
ence in neuronal cell numbers when compared with cre/wt
mice.
Our data represent first evidence for a role of HIF-1 for
dopaminergic development and survival. We also identified
an important downstream gene: VEGF. However, because
VEGF supplementation only partly antagonizes the lack of
HIF-1, future studies need to identify other downstream tar-
gets of HIF-1 that mediate this effect and may therefore rep-
resent potential drug targets for regeneration or protection of
SN dopaminergic neurons, the cell type selectively affected in
Parkinson’s disease.
References
Alvarez-Buylla A, Lim DA (2004) For the long run: maintaining germinal
niches in the adult brain. Neuron 41:683–686.
Betz UA, Vosshenrich CA, Rajewsky K, Muller W (1996) Bypass of lethality
with mosaic mice generated by Cre-loxP-mediated recombination. Curr
Biol 6:1307–1316.
Chavez JC, Baranova O, Lin J, Pichiule P (2006) The transcriptional activa-
tor hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-
dependent expression of erythropoietin in cortical astrocytes. J Neurosci
26:9471–9481.
Chung S, Hedlund E, HwangM, KimDW, Shin BS, Hwang DY, Jung Kang
U, Isacson O, Kim KS (2005) The homeodomain transcription factor
Pitx3 facilitates differentiation of mouse embryonic stem cells into
AHD2-expressing dopaminergic neurons. Mol Cell Neurosci
28:241–252.
Covello KL, Kehler J, Yu H, Gordan JD, Arsham AM, Hu CJ, Labosky PA,
Simon MC, Keith B (2006) HIF-2 regulates Oct-4: effects of hypoxia
on stem cell function, embryonic development, and tumor growth. Genes
Dev 20:557–570.
Demers EJ, McPherson RJ, Juul SE (2005) Erythropoietin protects dopami-
nergic neurons and improves neurobehavioral outcomes in juvenile rats
after neonatal hypoxia-ischemia. Pediatr Res 58:297–301.
Ema M, Hirota K, Mimura J, Abe H, Yodoi J, Sogawa K, Poellinger L,
Fujii-Kuriyama Y (1999) Molecular mechanisms of transcription ac-
tivation by HLF and HIF1 in response to hypoxia: their stabilization
and redox signal-induced interaction with CBP/p300. EMBO J
18:1905–1914.
Ferriero DM (2005) Protecting neurons. Epilepsia 46:45–51.
Gage FH (2003) Brain, repair yourself. Sci Am 289:46–53.
GerlachM, Gsell W, Kornhuber J, Jellinger K, Krieger V, Pantucek F, Vock
R, Riederer P (1996) A post mortem study on neurochemical mark-
ers of dopaminergic, GABA-ergic and glutamatergic neurons in basal
ganglia-thalamocortical circuits in Parkinson syndrome. Brain Res
741:142–152.
Greenberg DA, Jin K (2005) From angiogenesis to neuropathology. Nature
438:954–959.
Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, Ruas JL,
Poellinger L, Lendahl U, Bondesson M (2005) Hypoxia requires
notch signaling to maintain the undifferentiated cell state. Dev Cell
9:617–628.
Ivanovic Z, Dello Sbarba P, Trimoreau F, Faucher JL, Praloran V (2000)
Primitive human HPCs are better maintained and expanded in vitro at 1
percent oxygen than at 20 percent. Transfusion 40:1482–1488.
Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann
M, Gearhart JD, Lawler AM, Yu AY, Semenza GL (1998) Cellular and
developmental control of O2 homeostasis by hypoxia-inducible factor 1
. Genes Dev 12:149–162.
Jiang BH, Rue E,Wang GL, Roe R, Semenza GL (1996) Dimerization, DNA
binding, and transactivation properties of hypoxia-inducible factor 1.
J Biol Chem 271:17771–17778.
Junk AK,Mammis A, Savitz SI, SinghM, Roth S,Malhotra S, Rosenbaum PS,
Cerami A, Brines M, Rosenbaum DM (2002) Erythropoietin adminis-
tration protects retinal neurons from acute ischemia-reperfusion injury.
Proc Natl Acad Sci USA 99:10659–10664.
Le Y, Sauer B (2000) Conditional gene knockout using cre recombinase.
Methods Mol Biol 136:477–485.
Leclere N, Andreeva N, Fuchs J, Kietzmann T, Gross J (2004) Hypoxia-
induced long-term increase of dopamine and tyrosine hydroxylase
mRNA levels. Prague Med Rep 105:291–300.
Liss B, Haeckel O, Wildmann J, Miki T, Seino S, Roeper J (2005) K-ATP
channels promote the differential degeneration of dopaminergic mid-
brain neurons 8:1742–1751.
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data
using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
Methods 25:402–408.
MaingayM, Romero-RamosM, CartaM, Kirik D (2006) Ventral tegmental
area dopamine neurons are resistant to human mutant alpha-synuclein
overexpression. Neurobiol Dis 23:522–532.
Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A,
Sagara Y, Sisk A,Mucke L (2000) Dopaminergic loss and inclusion body
formation in alpha-synuclein mice: implications for neurodegenerative
disorders. Science 287:1265–1269.
MatsuzakiH, TamataniM, Yamaguchi A,NamikawaK,KiyamaH,VitekMP,
Mitsuda N, Tohyama M (2001) Vascular endothelial growth factor res-
cues hippocampal neurons fromglutamate-induced toxicity: signal trans-
duction cascades. FASEB J 15:1218–1220.
Milosevic J, Hoffarth S, Huber C, Schuler M (2003) The DNA damage-
induced decrease of Bcl-2 is secondary to the activation of apoptotic ef-
fector caspases. Oncogene 22:6852–6856.
Milosevic J, Schwarz SC, Krohn K, Poppe M, Storch A, Schwarz J (2005)
Low atmospheric oxygen avoids maturation, senescence and cell death
of murine mesencephalic neural precursors. J Neurochem
92:718–729.
Morrison SJ, Csete M, Groves AK, Melega W, Wold B, Anderson DJ (2000)
Culture in reduced levels of oxygen promotes clonogenic sympathoadre-
nal differentiation by isolated neural crest stem cells. J Neurosci
20:7370–7376.
Nagy A (2000) Cre recombinase: the universal reagent for genome tailoring.
Genesis 26:99–109.
Orb S, Wieacker J, Labarca C, Fonck C, Lester HA, Schwarz J (2004)
Knockin mice with Leu9’Ser 4-nicotinic receptors: substantia nigra do-
paminergic neurons are hypersensitive to agonist and lost postnatally.
Physiol Genomics 18:299–307.
Pfeifer A, Brandon EP, Kootstra N, Gage FH, Verma IM (2001) Delivery of
the Cre recombinase by a self-deleting lentiviral vector: efficient gene
targeting in vivo. Proc Natl Acad Sci USA 98:11450–11455.
Rajewsky K, Gu H, Kuhn R, Betz UA, Muller W, Roes J, Schwenk F (1996)
Conditional gene targeting. J Clin Invest 98:600–603.
Ryan HE, Lo J, Johnson RS (1998) HIF-1 is required for solid tumor for-
mation and embryonic vascularization. EMBO J 17:3005–3015.
Ryan HE, Poloni M,McNultyW, Elson D, GassmannM, Arbeit JM, Johnson
RS (2000) Hypoxia-inducible factor-1 is a positive factor in solid tu-
mor growth. Cancer Res 60:4010–4015.
SakanakaM,Wen TC,Matsuda S, Masuda S,Morishita E, NagaoM, Sasaki R
(1998) In vivo evidence that erythropoietin protects neurons from isch-
emic damage. Proc Natl Acad Sci USA 95:4635–4640.
Schnell PO, Ignacak ML, Bauer AL, Striet JB, Paulding WR, Czyzyk-Krzeska
MF (2003) Regulation of tyrosine hydroxylase promoter activity by the
von Hippel-Lindau tumor suppressor protein and hypoxia-inducible
transcription factors. J Neurochem 85:483–491.
Semenza GL (1999) Regulation of mammalian O2 homeostasis by hypoxia-
inducible factor 1. Annu Rev Cell Dev Biol 15:551–578.
420 • J. Neurosci., January 10, 2007 • 27(2):412–421 Milosevic et al. • HIF-1 and the Midbrain Dopaminergic Development
Sharpless NE, DePinho RA (2004) Telomeres, stem cells, senescence, and
cancer. J Clin Invest 113:160–168.
Silver I, Erecinska M (1998) Oxygen and ion concentrations in normoxic
and hypoxic brain cells. Adv Exp Med Biol 454:7–16.
Soucek T, Cumming R, Dargusch R, Maher P, Schubert D (2003) The reg-
ulation of glucose metabolism by HIF-1 mediates a neuroprotective re-
sponse to amyloid beta peptide. Neuron 39:43–56.
Storch A, Paul G, Csete M, Boehm BO, Carvey PM, Kupsch A, Schwarz J
(2001) Long-term proliferation and dopaminergic differentiation of hu-
man mesencephalic neural precursor cells. Exp Neurol 170:317–325.
Studer L, CseteM, Lee SH, KabbaniN,Walikonis J,Wold B,McKayR (2000)
Enhanced proliferation, survival, and dopaminergic differentiation of
CNS precursors in lowered oxygen. J Neurosci 20:7377–7383.
Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA (2003)
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after fo-
cal cerebral ischemia. J Clin Invest 111:1843–1851.
Tomita S, Ueno M, Sakamoto M, Kitahama Y, Ueki M, Maekawa N, Saka-
moto H, Gassmann M, Kageyama R, Ueda N, Gonzalez FJ, Takahama Y
(2003) Defective brain development in mice lacking the Hif-1 gene in
neural cells. Mol Cell Biol 23:6739–6749.
Wenger RH (2002) Cellular adaptation to hypoxia: O2-sensing protein hy-
droxylases, hypoxia-inducible transcription factors, and O2-regulated
gene expression. FASEB J 16:1151–1162.
Yasuhara T, Shingo T, Muraoka K, Kameda M, Agari T, Wen Ji Y, Hayase H,
Hamada H, Borlongan CV, Date I (2005) Neurorescue effects of VEGF
on a rat model of Parkinson’s disease. Brain Res 1053:10–18.
Milosevic et al. • HIF-1 and the Midbrain Dopaminergic Development J. Neurosci., January 10, 2007 • 27(2):412–421 • 421
